BioLife Sciences(OTC) BLFE

Current Price$0.00

Market Cap$4.80K

Since IPO (2020)-100%

5 Year-100%

1 Year+0%

1 Month+0%

BioLife Sciences last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-23

BioLife Sciences stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-16
1 month	+0%	USD 0.00	2026-06-23
3 month	+0%	USD 0.00	2026-04-24
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-07-23
3 year	+0%	USD 0.00	2023-07-24
5 year	-100%	USD 0.27	2021-07-23
Since inception	-100%	USD 2.35	2020-09-15

BioLife Sciences Financials at a Glance

Market Cap

$4.80K

Revenue (TTM)

$0.00

Net Income (TTM)

-$348.49K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

169.35 (High)

Dividend

$0.00

Beta (Volatility)

169.35 (High)

Price

$0.00

Volume

1,040

Open

$0.00

Price

$0.00

Volume

1,040

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

169.35 (High)

Price

$0.00

Volume

1,040

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

BLFE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioLife Sciences

BioLife Sciences Inc. specializes in the creation, licensing, and distribution of antibacterial solutions and advanced non-contact human temperature screening technologies. Established in 2018 and based in Mississauga, Canada, the company offers a diverse product portfolio aimed at enhancing public health and safety.

Products and Services

Sanitizing wipes for effective surface disinfection
Ultraviolet (UV) sterilization equipment for various applications
Touch-free vending systems for safe transactions

Growth Outlook

Expansion into new markets is anticipated to drive revenue growth
Increased demand for health and safety products post-pandemic
Innovative product development is expected to enhance market position

Financial Highlights

Recent quarterly net income reported at -132.05K
Trailing twelve months (TTM) revenue of 0
Current ratio at 0.094, indicating liquidity challenges

BioLife Sciences Inc. operates in the healthcare sector, focusing on medical instruments and supplies. The company has positioned itself to meet the growing demand for health and safety solutions, particularly in the wake of increased public awareness regarding hygiene and sanitation. Despite facing financial challenges, including a recent net income loss, the company is poised for potential growth through market expansion and innovative product offerings. The current financial metrics indicate a need for strategic management to improve liquidity and operational efficiency. Investors may find interest in the company's unique product line and its commitment to addressing contemporary health challenges.

AI Generated • Jul 27, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Henderson, NV 89052, US

BLFE Financials

Key Financial Metrics (TTM)

Gross Margin

-239.25%

Operating Margin

-302.17%

Net Income Margin

-307.99%

Return on Equity

367.14%

Return on Capital

N/A

Return on Assets

-1743.72%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.80K

Shares Outstanding

4.83B

Volume

1.04K

Avg. Volume

106.42K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$318.42K

EBITDA

-$319.27K

Operating Cash Flow

-$95.84K

Capital Expenditure

$0.00

Free Cash Flow

-$95.84K

Cash & ST Invst.

$15.62

Total Debt

$398.00

BioLife Sciences Performance Analysis

BioLife Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2021-02-28	N/A
Q2	2021-05-31	N/A
Q3	2021-08-31	N/A
Q1	2022-02-28	N/A

BioLife Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2021-02-28	N/A
Q2	2021-05-31	-108.3%
Q3	2021-08-31	-4.0%
Q1	2022-02-28	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2022YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.80K

N/A

Market Cap/Employee

$1.60K

N/A

Employees

N/A

Net Income

-$132.05

+99.5%

EBITDA

$0.00

-100.0%

Quarterly Fundamentals

Name

Q1 2022YOY CHG

Total Cash

$15.62

-100.0%

Total Debt

$398.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$10.62

-100.0%

Short Term Debt

$387.38

-100.0%

Return on Assets

-17.44%

N/A

Return on Invested Capital

1.80%

N/A

Free Cash Flow

-$1.96

+100.0%

Operating Cash Flow

-$1.96

+100.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PHRXPharmagen, Inc.

PHRXPharmagen, Inc.$0.00+0.00%

BIOAFBioasis Technologies Inc.

BIOAFBioasis Technologies Inc.$0.00+0.00%

SHWZMedicine Man Technologies, Inc.

SHWZMedicine Man Technologies, Inc.$0.00+0.00%

TOMDFTodos Medical Ltd.

TOMDFTodos Medical Ltd.$0.00+0.00%

EMYSFEasy Technologies Inc.

EMYSFEasy Technologies Inc.$0.02+0.00%

NVNOenVVeno Medical Corporation

NVNOenVVeno Medical Corporation$10.39+2.77%

WHSIWearable Health Solutions, Inc.

WHSIWearable Health Solutions, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

NOKNokia

NOKNokia$9.10-0.06%

STAKStak

STAKStak$9.27+6.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$31.27-0.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.79+0.04%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$684.23-0.01%

Questions About BLFE

What is the current price of BioLife Sciences?

BioLife Sciences is trading at $0.00 per share.

What is the 52-week range for BioLife Sciences?

Over the past 52 weeks, BioLife Sciences has traded between $0.00 and $0.01.

How much debt does BioLife Sciences have?

BioLife Sciences total debt is unavailable.

How much cash does BioLife Sciences have on hand?

BioLife Sciences does not have cash on hand data available.

What is BioLife Sciences’s dividend yield?

BioLife Sciences does not currently have a dividend yield.

BioLife Sciences(OTC) BLFE

BioLife Sciences Financials at a Glance

BLFE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioLife Sciences

BLFE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioLife Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BLFE

What is the current price of BioLife Sciences?

What is the 52-week range for BioLife Sciences?

How much debt does BioLife Sciences have?

How much cash does BioLife Sciences have on hand?

What is BioLife Sciences’s dividend yield?

Premium Investing Services